1. Primary hyperparathyroidism in prostate cancer: guilty or not guilty?
   G. Mazziotti et al, 2018, Endocrine CrossRef
2. Involvement of Par-4 in Breast Cancer
   Simone Aparecida de Bessa-Garcia et al, 2021, Tumor Suppressor Par-4 CrossRef
3. Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC)
   Paulo R de Alcantara Filho et al, 2018, Breast Cancer Management CrossRef
4. Par-4 in Chemoresistant Ovarian and Endometrial Cancers
   François Fabi et al, 2021, Tumor Suppressor Par-4 CrossRef
5. Discovery and Overview of Par-4
   Saptadwipa Ganguly et al, 2022, Tumor Suppressor Par-4 CrossRef
6. Role of Par-4 in B-Cell Hematological Malignancies
   Sunil K. Noothi et al, 2021, Tumor Suppressor Par-4 CrossRef
7. Roles for Par-4 in Kidney Pathophysiology
   Lu Ren et al, 2021, Tumor Suppressor Par-4 CrossRef
8. Characterizing the Wnt Pathway in Advanced Prostate Cancer: When, Why, and How
   Sumanta K. Pal et al, 2020, European Urology CrossRef
9. Vitamin D Modulates PAR-4 Expression in an in Vitro Model of Osteoarthritis
   Vanessa Mylenna Florêncio de Carvalho et al, 2022, Brazilian Archives of Biology and Technology CrossRef
10. Targeting the Wnt/β-catenin signaling pathway in cancer
    Ya Zhang et al, 2020, Journal of Hematology & Oncology CrossRef
11. Identification and characterization of biomarkers and their functions for docetaxel‑resistant prostate cancer cells
    Leihong Deng et al, 2019, Oncology Letters CrossRef
12. Abnormal Long Non-Coding RNAs Expression Patterns Have the Potential Ability for Predicting Survival and Treatment Response in Breast Cancer
    Ana Carolina Pavanelli et al, 2021, Genes CrossRef